Page 472 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 472

Chapter 29  Inherited Bone Marrow Failure Syndromes  393

            SUGGESTED READINGS                                    Congenital Amegakaryocytic Thrombocytopenia

            General                                               Ballmaier  M,  Germeshausen  M:  Congenital  amegakaryocytic  thrombocy-
                                                                    topenia:  clinical  presentation,  diagnosis,  and  treatment.  Semin Thromb
            Cada M, Segbefia CI, Klaassen R, et al: The impact of category, cytopathology   Hemost 37(6):673–681, 2011.
              and cytogenetics on development and progression of clonal and malignant
              myeloid  transformation  in  inherited  bone  marrow  failure  syndromes.   Diamond-Blackfan Anemia
              Haematologica 100:633–642, 2015.
            Chirnomas SD, Kupfer GM: The inherited bone marrow failure syndromes.
              Pediatr Clin North Am 60:1291–1310, 2013.           Ellis SR, Gleizes PE: Diamond Blackfan anemia: ribosomal proteins going
            Tsangaris E, Klaassen R, Fernandez CV, et al: Genetic analysis of inherited   rogue. Semin Hematol 48:89, 2011.
              bone  marrow  failure  syndromes  from  one  prospective,  comprehensive   Horos R, von Lindern M: Molecular mechanisms of pathology and treatment
              and population-based cohort and identification of novel mutations. J Med   in Diamond Blackfan anaemia. Br J Haematol 159:514–527, 2012.
              Genet 48:618, 2011.                                 Vlachos  A,  Blanc  L,  Lipton  JM:  Diamond  Blackfan  anemia:  a  model  for
                                                                    the translational approach to understanding human disease. Expert Rev
                                                                    Hematol 7:359–372, 2014.
            Fanconi Anemia
                                                                  Congenital Dyserythropoietic Anemias
            Auerbach AD: Fanconi anemia and its diagnosis. Mutat Res 668:4, 2009.
            Longerich  S,  Li  J,  Xiong  Y,  et al:  Stress  and  DNA  repair  biology  of  the
              Fanconi anemia pathway. Blood 124(18):2812–2819, 2014.  Iolascon A, Heimpel H, Wahlin A, et al: Congenital dyserythropoietic anemias:
            Quentin  S,  Cuccuini  W,  Ceccaldi  R,  et al:  Myelodysplasia  and  leukemia   molecular insights and diagnostic approach. Blood 122:2162–2166, 2013.
              of  Fanconi  anemia  are  associated  with  a  specific  pattern  of  genomic   Wickramasinghe  SN,  Wood  WG:  Advances  in  the  understanding  of  the
              abnormalities  that  includes  cryptic  RUNX1/AML1  lesions.  Blood   congenital dyserythropoietic anaemias. Br J Haematol 131:431, 2005.
              117:e161–e170, 2011.
                                                                  Kostmann/Severe Congenital Neutropenia
            Shwachman-Diamond Syndrome
                                                                  Dale DC, Welte K: Cyclic and chronic neutropenia. Cancer Treat Res 157:97,
            Donadieu J, Fenneteau O, Beaupain B, et al: Classification of and risk factors   2011.
              for hematologic complications in a French national cohort of 102 patients   Grenda DS, Murakami M, Ghatak J, et al: Mutations of the ELANE gene
              with Shwachman-Diamond syndrome. Haematologica 97(9):1312–1319,   found in patients with severe congenital neutropenia induce the unfolded
              2012.                                                 protein response and cellular apoptosis. Blood 110:4179, 2007.
            Finch AJ, Hilcenko C, Basse N, et al: Uncoupling of GTP hydrolysis from   Hauck  F,  Klein  C:  Pathogenic  mechanisms  and  clinical  implications  of
              eIF6  release  on  the  ribosome  causes  Shwachman-Diamond  syndrome.   congenital  neutropenia  syndromes.  Curr  Opin  Allergy  Clin  Immunol
              Genes Dev 25:917, 2011.                               13(6):596–606, 2013.
            Hashmi SK, Allen C, Klaassen R, et al: Comparative analysis of Shwachman-  Makaryan V, Zeidler C, Bolyard AA, et al: The diversity of mutations and
              Diamond syndrome to other inherited marrow failure syndromes. Clin   clinical outcomes for ELANE-associated neutropenia. Curr Opin Hematol
              Genet 79:448, 2011.                                   22(1):3–11, 2015.
            Sen S, Wang H, Nghiem CL, et al: The ribosome-related protein, SBDS, is   Rosenberg PS, Zeidler C, Bolyard AA, et al: Stable long-term risk of leukae-
              critical for normal erythropoiesis. Blood 118:6407, 2011.  mia in patients with severe congenital neutropenia maintained on G-CSF
                                                                    therapy. Br J Haematol 150:196, 2010.
                                                                  Skokowa J, Fobiwe JP, Dan L, et al: Neutrophil elastase is severely down-
            Dyskeratosis Congenita                                  regulated  in  severe  congenital  neutropenia  independent  of  ELANE  or
                                                                    HAX1 mutations but dependent on LEF-1. Blood 114:3044, 2009.
            Alter BP, Giri N, Savage SA, et al: Cancer in dyskeratosis congenita. Blood   Skokowa  J,  Steinemann  D,  Katsman-Kuipers  JE,  et al:  Cooperativity  of
              113:6549, 2009.                                       RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique
            Ballew BJ, Savage SA: Updates on the biology and management of dyskera-  pathway in myeloid leukemogenesis. Blood 123:2229–2237, 2014.
              tosis congenita and related telomere biology disorders. Expert Rev Hematol
              6(3):327–337, 2013.
   467   468   469   470   471   472   473   474   475   476   477